COVID Treatment & Management
Sort by:
Mayo Clinic Proceedings
Resuscitation & COVID-19: Patient & Family Expectations During Pandemic
FEATURING
Taimur Sher
- 7 views
- September 9, 2020
This Week in Virology (TWiV)
Human Mpox Virus Infection in Women and Non-binary Individuals During the 2022 Outbreaks, Changes in Population Immunity Against Infection and Severe Disease From SARS-CoV-2 Omicron Variants in the United States, and Angiotensin Receptor Blockers for the Treatment of COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 7 views
- January 28, 2023
Mayo Clinic Proceedings
Changes in Burnout in Physicians Over the First 2 Years of COVID-19
FEATURING
Tait Shanafelt
- 6 views
- January 28, 2023
MedCram
Vilobelimab for Severe COVID-19: Are There Possible Applications in the Treatment of Other Diseases?
FEATURING
Roger Seheult
- 6 views
- August 2, 2023
This Week in Virology (TWiV)
Molnupiravir-Associated Mutational Signature in Global SARS-CoV-2 Genomes, Inhaled Fluticasone Furoate for Outpatient Treatment of COVID-19, and Autonomic Dysregulation in Long-Term Patients Suffering from Post-COVID-19 Syndrome
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- October 5, 2023
This Week in Virology (TWiV)
Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics, Excess Mortality Estimates Associated With the COVID-19 Pandemic, and COVID-19 reveals Associations Between Individual Symptoms and Inflammatory Indexes
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- January 28, 2023
This Week in Virology (TWiV)
New Risk Assessment for the H5N1 Avian Flu Viruses, Repeated Antibiotic Exposure and Risk of Hospitalization and Death Following COVID-19 Infection, and Long Term Follow-Up of a Multicenter Cohort of COVID-19 Patients with Pulmonary Embolism
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- August 2, 2023
MicrobeTV
Outcomes of SARS-CoV-2, Influenza and RSV Infection in Pediatric Communities, Influence of Exposure Length on Transmission of SARS-CoV-2, and Effect of Vaccination on Post-COVID Conditions in Children Between 5-17 Years Old
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- January 2, 2024
This Week in Virology (TWiV)
Four Things to Know About RSV, a Systematic Review of the Clinical Effectiveness of Tixagevimab/Cilgavimab for Prophylaxis of COVID-19 in Immunocompromised Patients, and Long-Lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- January 28, 2023
MedCram
Interferon's Role in SARS-CoV2 Infection and the Role of Hydrotherapy
FEATURING
Roger Seheult
- 5 views
- November 14, 2023
This Week in Virology (TWiV)
Influenza Hemagglutinin Stem Nanoparticle Vaccine Induces Cross-Group 1 Neutralizing Antibodies in Healthy Adults, Impact of SARS-CoV-2 Variants on Inpatient Clinical Outcome, and Gut Microbiota Derived Symbiotic Formula (SIM01) as a Novel Adjuvant Therapy for COVID‐19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 5 views
- August 3, 2023
This Week in Virology (TWiV)
Effectiveness of Influenza Vaccination of Pregnant Women, Real-world Evidence of Novel Treatments for COVID-19 on Mortality, and Effectiveness and Safety of Extended Thromboprophylaxis in Post-discharge Patients with COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 5 views
- January 28, 2023
This Week in Virology (TWiV)
Infectiousness of SARS-CoV-2 Breakthrough Infections and Reinfections During the Omicron Wave, SARS-CoV-2 Infection and Persistence in the Human Body and Brain at Autopsy, and increased Heart Disease Risk After COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 5 views
- January 28, 2023
McMaster University Department of Medicine
Tackling Epidemics in Africa with Science
FEATURING
Salim Abdool Karim,
Quarraisha Abdool Karim
- 4 views
- January 28, 2023
This Week in Virology (TWiV)
The Epidemiology of Long COVID-19 in US Adults, Persistent Symptoms and Sequelae After SARS-CoV-2 Infection Not Requiring Hospitalization, Outpatient Treatment of COVID-19 with Metformin, Ivermectin, and Fluvoxamine and the Development of Long COVID-19 over 10-month Follow-Up
FEATURING
Daniel Griffin,
Vincent Racaniello
- 4 views
- January 28, 2023